SUPN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

3.82

Margin Of Safety %

Put/Call OI Ratio

0.99

EPS Next Q Diff

-0.49

EPS Last/This Y

4.37

EPS This/Next Y

0.31

Price

29.72

Target Price

45.67

Analyst Recom

1.33

Performance Q

-1.99

Upside

325.1%

Beta

-0.58

Ticker: SUPN

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-15	SUPN	39.56	4.28	1.00	1839
2026-10-16	SUPN	37.87	4.32	1.52	1841
2026-10-19	SUPN	39.81	3.85	0.00	1772
2026-10-20	SUPN	41.15	3.83	999.99	1773
2026-10-21	SUPN	41.2	3.84	0.40	1775
2026-10-22	SUPN	42.08	3.84	0.40	1775
2026-10-23	SUPN	40.66	3.85	0.00	1775
2026-10-26	SUPN	40.78	3.85	0.00	1775
2026-10-27	SUPN	40.93	3.85	1.00	1775
2026-10-28	SUPN	41.15	3.85	0.50	1775
2026-10-29	SUPN	41.84	3.85	0.50	1775
2026-10-30	SUPN	41.94	3.84	0.00	1763
2026-11-02	SUPN	41.92	3.84	11.00	1763
2026-11-03	SUPN	28.15	3.77	0.20	1745
2026-11-04	SUPN	28.27	1.08	0.06	22565
2026-11-05	SUPN	26.76	1.04	14.00	23068
2026-11-06	SUPN	26.18	1.06	1.19	22911
2026-11-09	SUPN	27.62	1.06	0.19	22877
2026-11-10	SUPN	28.77	1.06	0.01	22898
2026-11-11	SUPN	29.45	1.00	0.16	23621
2026-11-12	SUPN	29.21	0.99	0.14	23693
2026-11-13	SUPN	29.72	0.99	0.04	23679
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-15	SUPN	39.55	1.2	-	2.56
2026-10-16	SUPN	37.85	1.2	-	2.56
2026-10-19	SUPN	39.78	1.2	-	2.56
2026-10-20	SUPN	39.78	1.2	-	2.56
2026-10-21	SUPN	41.22	-8.7	-	2.54
2026-10-22	SUPN	42.08	-8.7	-	2.54
2026-10-23	SUPN	40.67	-8.7	-	2.54
2026-10-26	SUPN	40.78	-19.4	-	2.38
2026-10-27	SUPN	40.93	-19.4	-	2.38
2026-10-28	SUPN	41.15	-19.4	-	2.38
2026-10-29	SUPN	41.85	-19.4	-	2.38
2026-10-30	SUPN	41.95	-19.4	-	2.38
2026-11-02	SUPN	41.94	-19.4	-	2.38
2026-11-03	SUPN	28.19	17.3	-	2.77
2026-11-04	SUPN	28.27	17.3	-	2.77
2026-11-05	SUPN	26.77	17.3	-	2.77
2026-11-06	SUPN	26.17	48.8	-	4.42
2026-11-09	SUPN	27.63	48.8	-	4.42
2026-11-10	SUPN	28.75	48.8	-	3.44
2026-11-11	SUPN	29.42	48.8	-	3.44
2026-11-12	SUPN	29.20	25.6	-	3.69
2026-11-13	SUPN	29.72	25.6	-	3.69
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-15	SUPN	0.00	1.52	9.14
2026-10-16	SUPN	0.00	1.52	9.14
2026-10-19	SUPN	0.00	1.45	9.14
2026-10-20	SUPN	0.00	1.45	9.14
2026-10-21	SUPN	0.00	1.45	9.14
2026-10-22	SUPN	0.00	1.45	9.14
2026-10-23	SUPN	0.00	1.45	9.14
2026-10-26	SUPN	0.00	2.16	9.14
2026-10-27	SUPN	0.00	2.16	7.42
2026-10-28	SUPN	0.00	2.16	7.42
2026-10-29	SUPN	0.00	2.16	7.42
2026-10-30	SUPN	0.00	2.16	7.42
2026-11-02	SUPN	0.00	2.29	7.41
2026-11-03	SUPN	0.00	2.29	3.34
2026-11-05	SUPN	0.00	2.29	3.34
2026-11-06	SUPN	0.00	2.29	3.34
2026-11-09	SUPN	0.00	-4.51	3.34
2026-11-10	SUPN	0.00	-4.51	3.34
2026-11-11	SUPN	0.00	-4.51	3.82
2026-11-12	SUPN	0.00	-4.51	3.82
2026-11-13	SUPN	0.00	-4.51	3.82
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.32

Avg. EPS Est. Current Quarter

1.03

Avg. EPS Est. Next Quarter

0.83

Insider Transactions

Institutional Transactions

-4.51

Beta

-0.58

Average Sales Estimate Current Quarter

371

Average Sales Estimate Next Quarter

392

Fair Value

34.37

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

50.2

Max Drawdown 5-Year %

-54.1

Target Price

45.67

P/E

8.23

Forward P/E

7.65

PEG

0.37

P/S

4.49

P/B

P/Free Cash Flow

237.81

EPS

3.61

Average EPS Est. Cur. Y

3.69

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

32.75

Relative Volume

0.62

Return on Equity vs Sector %

-30.5

Return on Equity vs Industry %

-10.8

EPS 1 7Days Diff

-0.7

EPS 1 30Days Diff

-0.72

EBIT Estimation

◆ SUPN Healthcare

$29.72

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

12/25

Volume

6/15

Valuation

18/20

TP/AR

2/10

Options

2/10

RSI

63.6

Range 1M

34.4%

Sup Dist

3.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

24/30

Estimates

4/20

Inst/Vol

1/15

Options

4/10

EPS Yr

23.5%

EPS NY

25.8%

52W%

22.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +201% upside

Quality

8/30

Valuation

25/30

Growth

20/25

Stability

6/10

LT Trend

1/5

Upside

+201%

Quality

MoS

16%

SUPN — P/E HistoricalDrug Manufacturers - Specialty & Generic

Supernus, Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 827

Supernus, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Supernus, Inc. was formerly known as Indivior Pharmaceuticals, Inc. and changed its name Supernus, Inc. in November 2026. Supernus, Inc. was incorporated in 2014 and is headquartered in Rockville, Maryland.

SUPN

Latest News

—

Caricamento notizie per SUPN…

stock quote shares SUPN – Supernus Pharmaceuticals Inc Stock Price stock today

news today SUPN – Supernus Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch SUPN – Supernus Pharmaceuticals Inc yahoo finance google finance

stock history SUPN – Supernus Pharmaceuticals Inc invest stock market

stock prices SUPN premarket after hours

ticker SUPN fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SUPN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y